Search results
HIV Risk and Interest in Preexposure Prophylaxis in Justice-Involved Persons
Centers for Disease Control and Prevention· 2 days agoHIV Risk and Interest in Preexposure Prophylaxis
OraSure Technologies (NASDAQ:OSUR) Upgraded to Buy by StockNews.com
ETF DAILY NEWS· 5 days agoStockNews.com upgraded shares of OraSure Technologies (NASDAQ:OSUR – Free Report) from a hold rating to a buy rating in a report issued on Wednesday. Separately, Evercore ISI cut their price ...
MedMira Announces the Hire of Vice President of Business Development
Digital Journal· 6 days agoBased on its patented Rapid Vertical Flow ® Technology, MedMira's rapid HIV test is the only one in the world to achieve ...
Study highlights importance of early interventions to combat HIV
Medical Xpress· 7 days agoThe strength of evidence, described as convincing, supports the conclusion that, although early treatment does not prevent the formation of HIV reservoirs, it is associated ...
“Super Gonorrhea” Has Arrived
Journal of the American Medical Association· 4 days agoThe clock is ticking on effective gonorrhea treatments—some say since 2018, when researchers in the UK reported the first Neisseria gonorrhoeae strain...
Afinitor interactions: Other medications, alcohol, and more
Medical News Today· 4 days agoAfinitor has interactions with some other drugs and certain supplements. Before you start treatment...
mRNA Vaccines: Not Just for COVID Soon?
Medscape· 5 days agoTo date, mRNA vaccines have had their largest global presence in combating the COVID-19 pandemic. Intensive research is underway on many other potential...
Short questions with Dana Perino for Dr. Marc Siegel
Fox News via Yahoo News· 5 days agoFox News medical contributor Dr. Marc Siegel shares with Dana Perino what drew him to medicine, what constitutes effective leadership in health care and...
What is Shigella? As infections caused by sexual transmission rise
Yahoo Life UK· 7 days agoWith a rise in antibiotic-resistant cases across the UK, here's everything you need to know, from...
Q1 2024 Vir Biotechnology Inc Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 4 days agoIn addition, we are developing a cocktail of drug neutralizing antibodies for an HIV cure. We look forward to sharing more about these programs during the course of the year ...
